Hydroquinine pharmacokinetics after oral administration in adult patients with muscle cramps

European Journal of Clinical Pharmacology

Volumn 56, Issue 3, 2000, Pages 263-267

  Van Kan, H J M ^a,b   Jansen, P H P ^a   Tuinte, C ^c   Smits, P ^c   Verbeek, A L M ^c  

^a GELDERSE VALLEI HOSPITAL   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Department of Neurology ^*

Author keywords

Hydroquinine; Muscle cramps; Pharmacokinetics

Indexed keywords

HYDROQUININE; INHIBIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; DRUG CLEARANCE; DRUG HALF LIFE; DRUG SALIVA LEVEL; DRUG TISSUE LEVEL; FEMALE; HEADACHE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MUSCLE CRAMP; MYALGIA; PRIORITY JOURNAL; TASTE AVERSION; TINNITUS; VERTIGO;

ADMINISTRATION, ORAL; ADULT; FEMALE; HUMANS; HYDROQUINONES; MALE; MIDDLE AGED; MUSCLE CRAMP;

EID: 0033920671     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280000128     Document Type: Article

References (16)

1. 1. Man-Son-Hing M, Wells G (1995) Meta-analysis of efficacy of quinine for treatment of nocturnal leg cramps in elderly people. BMJ 310: 13-17
2. 2. Jansen PHP, Veenhuizen KCW, Wesseling AIM, et al (1997) Randomised controlled trial of hydroquinine in muscle cramps. Lancet 349: 528-532
3. 3. Jansen PHP, Veenhuizen KCW, Verbeek ALM, et al (1994) Efficacy of hydroquinine in preventing frequent ordinary muscle cramp outlasts actual administration. J Neurol Sci 122: 157-161
4. 4. Warburton A, Royston JP, O'Neill CJA, et al (1987) A quinine a day keeps the leg cramps away. Br J Clin Pharmacol 23: 459-465
5. 5. Edwards G, Winstanley PA, Ward SA (1994) Clinical pharmacokinetics in the treatment of tropical diseases. Some applications and limitations. Clin Pharmacokinet 27: 150-165
6. 6. Babalola CP, Bolaji OO, Dixon PAF, Ogunbona FA (1993) Column liquid Chromatographic analysis of quinine in human plasma, saliva and urine. J Chromatogr 616: 151-154
7. 7. Cramer G, Isaksson B (1963) Quantitative determination of quinidine in plasma. Scand J Clin Lab Invest 15: 553-556
8. 8. Mberu EK, Ward SA, Winstanley PA, Watkins WM (1991) Measurement of quinine in filter paper-absorbed blood by high-performance liquid chromatography. J Chromatogr 570: 18-14
9. 9. Leroyer R, Jarreau C, Pays M, Varoquaux O, Advenier C (1984) Reverse-phase liquid chromatography and pharmacokinetic study of two hydroxylated analogues of quinidine in dogs. J Pharm Sci 73: 844-846
10. 10. Proost JH, Meijer DKF (1992) MW/Pharm, an integrated software package for drug dosage regimen calculation and therapeutic drug monitoring. Comput Biol Med 22: 155-163
11. 11. Claessen FAP, Van Boxtel CJ, Perenboom RM, et al (1998) Quinine pharmacokinetics: ototoxic and cardiotoxic effects in healthy Caucasian subjects and in patients with falciparum malaria. Trop Med Int Health 3: 482-499
12. 12. Krishna S, White NJ (1996) Pharmacokinetics of quinine, chloroquine and amodiaquinine. Clin Pharmacokinet 30: 263-299
13. 13. Narang PK, Carliner NH, Fisher ML, Crouthamel WG (1983) Quinidine saliva concentrations: absence of correlation with serum concentrations at steady state. Clin Pharmacol Ther 34: 695-702
14. 14. Silamut K, Molunto P, Ho M, Davis TM, White NJ (1991) Alpha 1-acid glycoprotein (orosomucoid) and plasma protein binding of quinine in falciparum malaria. Br J Clin Pharmacol 32: 311-315
15. 15. Ochs HR, Greenblatt DJ, Woo E (1980) Clinical pharmacokinetics of quinidine. Clin Pharmacokinet 5: 150-168
16. 16. Wanwimolruk S, Chalcroft S, Coville PF, Campbell AJ (1991) Pharmacokinetics of quinine in young and elderly subjects. Trans R Soc Trop Med Hyg 85: 714-717